DEL-AI Discovery Engine
Provider 
Founded 2012
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public

Nurix AI-enhanced DEL discovery engine for targeted protein degradation programs.
The DEL-AI Discovery Engine is Nurix Therapeutics' AI-enhanced DNA-encoded library discovery engine. It powers the company's targeted protein degradation and molecular glue programs by identifying small-molecule ligands against disease-relevant targets.
The platform combines DNA-encoded library technology with machine learning to accelerate hit identification and lead optimization for targeted protein degradation.
Adds products that compete with one of DEL-AI Discovery Engine’s direct competitors but not with DEL-AI Discovery Engine itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | DEL-AI Discovery Engine | Eclipsor | PROTAC Discovery Engine | TORPEDO Platform | |
|---|---|---|---|---|---|
| Linked Through | — | Direct competitor | Eclipsor | Eclipsor | |
| Provider | |||||
| Founded | 2012 | 2006 | 2013 | 2015 | |
| Sells To | Enterprise | Businesses | Enterprise | Enterprise | |
| Pricing Model | Recurring, Software | Pre-Revenue | Recurring, Software | Recurring, Software | |
| Ownership | Public | Private | Public | Venture-backed |
Provider 
Founded 2012
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public
Provider 
Founded 2006
Sells To Businesses
Pricing Model Pre-Revenue
Ownership Private
Linked Through Eclipsor
Provider 
Founded 2013
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public
Linked Through Eclipsor
Provider 
Founded 2015
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed


Arvinas' PROTAC discovery engine for developing targeted protein degrader therapeutics.

Arvinas' PROTAC discovery engine for developing targeted protein degrader therapeutics.

C4 Therapeutics platform for discovering targeted protein degraders.
